vidarabine has been researched along with Cardiomyopathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gomi, K; Hayakawa, Y; Ishikawa, M; Ito, A; Kiyomoto, K; Matsuo, I; Mitsubayashi, T; Morii, A; Mototani, Y; Nariyama, M; Ohnuki, Y; Okumura, S; Suita, K; Tsunoda, M | 1 |
| Boey, ML; Lee, YS; Mak, KH; Wan, SH | 1 |
2 other study(ies) available for vidarabine and Cardiomyopathies
| Article | Year |
|---|---|
Vidarabine, an anti-herpes agent, improves Porphyromonas gingivalis lipopolysaccharide-induced cardiac dysfunction in mice.
Topics: Animals; Cardiomyopathies; Heart; Lipopolysaccharides; Mice; Porphyromonas gingivalis; Vidarabine | 2023 |
Myocardial and skeletal muscle injuries following adenine arabinoside therapy.
Topics: Acute Disease; Adult; Cardiomyopathies; Hepatitis B; Hepatitis, Chronic; Humans; Male; Myositis; Vidarabine | 1990 |